Skip to main content
National News Desk
health

Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO

Hindustan Times IndiaBy Hindustan Times India
17 Nov 2026
Original: English
AI Synopsis & Key Briefing

The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic Republic of the Congo (DRC).

Key Highlights & Official Takeaways
  • ✓The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic Republic of the Congo (DRC).
  • ✓Primary Authority: Official communique verified from Hindustan Times India.
  • ✓Civic Domain: Categorized under health public notices.
Comprehensive News & Policy Report

The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic Republic of the Congo (DRC).

According to the formal briefing communicated by Hindustan Times India, this announcement has been instituted to ensure enhanced transparency, efficiency, and public accessibility across civic and administrative operations. The issuing authority has instructed all affiliated directorates and nodal offices to adhere strictly to the notified procedural roadmap.

This policy and administrative communique directly impacts citizens and aspirants navigating health, public sector career pathways, and institutional programs. Comprehensive guidelines, eligibility caveats, and official procedural calendars are being disseminated through verified channels. Stakeholders are strongly encouraged to rely on verified government communiques to avoid misinformation.

Actionable Steps for Aspirants & Citizens
  • •Aspirants and citizens are advised to monitor official notices and circulars issued by Hindustan Times India.
  • •Verify all prescribed eligibility criteria, cutoff dates, and authenticated document requirements prior to formal submissions.
  • •Track connected examination timetables, vacancy advisories, and administrative gazettes on SuchnaSetu.
Official Notice Specification
Issuing AuthorityHindustan Times India
Topic CategoryHEALTH
JurisdictionAll India / National
Publication Date17 November 2026
Connected Government Jobs & Upcoming Exams
Active on SuchnaSetu
Official Source Attribution: Hindustan Times India
View Publisher Source Link

SuchnaSetu provides verified civic and public policy reports based on official notices. Primary publication and copyright remain with the respective government authority or publisher.